John Alexander Kelly - 29 Feb 2024 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Financial Officer
Signature: /s/ Dario Scimeca, Attorney-in-fact for John Alexander Kelly
Issuer symbol: DTIL
Transactions as of: 29 Feb 2024
Net transactions value: +$9,361
Form type: 4
Filing time: 03 May 2024, 18:34:29 UTC
Previous filing: 23 Jan 2024
Next filing: 22 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Award	$9,361	+506	+2.5%	$18.50	20,978	29 Feb 2024	Direct	F1
transaction	DTIL	Common Stock	Options Exercise		+1,702	+8.1%		22,680	01 May 2024	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Restricted Stock Units	Options Exercise	$0	-1,702	-50%	$0.000000	1,702	01 May 2024	Common Stock	1,702		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split.
F2	Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024.
F3	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F4	On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.